Assessing a Regorafenib-irinotecan Combination Versus Regorafenib Alone in Metastatic Colorectal Cancer Patients
Assessing a Regorafenib-irinotecan Combination Versus Regorafenib Alone in Metastatic Colorectal Cancer Patients
Active, not recruiting · NCT03829462 · Registry updated 2025-11-21Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Assessing a Regorafenib-irinotecan Combination Versus Regorafenib Alone in Metastatic Colorectal Cancer Patients | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Active, not recruiting | Phase 3 | 2025-11-21 | NCT03829462 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Institut du Cancer de Montpellier - Val d'Aurelle | 67 |
11 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Antoine Lacassagne | Nice | France | 2 |
| Centre François Baclesse | Caen | France | 1 |
| Centre Léon Bérard | Lyon | France | 2 |
| CRLC Val d'Aurelle-Paul Lamarque | Montpellier | France | 1 |
| Hôpital Européen Georges Pompidou | Paris | France | 37 |
| Hôpital Pontchaillou | Rennes | France | 1 |
| Hôpital privé Jean Mermoz | Lyon | France | 1 |
| Hôpital Robert Debré | Reims | France | 1 |
| Hôpital Saint-Jean | Perpignan | France | 2 |
| Institut Godinot | Reims | France | 2 |
| Institut Gustave Roussy | Villejuif | France | 1 |